VIVANZAPharmaceuticals
Vivanza Biosciences Ltd — Balance Sheet
₹1.76
+0.00%
Vivanza Biosciences Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 4.00 Cr | 4.00 Cr | 4.00 Cr | 4.00 Cr | — |
| Share Issued | 4.00 Cr | 4.00 Cr | 4.00 Cr | 4.00 Cr | — |
| Net Debt | 8.54 Cr | 5.00 Cr | 7.86 Cr | 5.45 Cr | — |
| Total Debt | 8.65 Cr | 5.17 Cr | 8.00 Cr | 5.51 Cr | — |
| Tangible Book Value | 2.33 Cr | 3.00 Cr | 2.46 Cr | 1.86 Cr | — |
| Invested Capital | 12.62 Cr | 9.81 Cr | 12.09 Cr | 9.00 Cr | — |
| Working Capital | 3.23 Cr | 3.56 Cr | 2.60 Cr | 2.98 Cr | — |
| Net Tangible Assets | 2.33 Cr | 3.00 Cr | 2.46 Cr | 1.86 Cr | — |
| Common Stock Equity | 3.96 Cr | 4.64 Cr | 4.09 Cr | 3.49 Cr | — |
| Total Capitalization | 7.30 Cr | 7.32 Cr | 5.52 Cr | 6.09 Cr | — |
| Total Equity Gross Minority Interest | 3.96 Cr | 4.64 Cr | 4.09 Cr | 3.49 Cr | — |
| Stockholders Equity | 3.96 Cr | 4.64 Cr | 4.09 Cr | 3.49 Cr | — |
| Other Equity Interest | -0.04 Cr | 0.64 Cr | 0.09 Cr | -0.51 Cr | — |
| Capital Stock | 4.00 Cr | 4.00 Cr | 4.00 Cr | 4.00 Cr | — |
| Common Stock | 4.00 Cr | 4.00 Cr | 4.00 Cr | 4.00 Cr | — |
| Total Liabilities Net Minority Interest | 12.49 Cr | 14.86 Cr | 18.39 Cr | 12.07 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 3.33 Cr | 2.68 Cr | 1.43 Cr | 2.60 Cr | — |
| Non Current Deferred Taxes Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Long Term Debt And Capital Lease Obligation | 3.33 Cr | 2.68 Cr | 1.43 Cr | 2.60 Cr | — |
| Long Term Debt | 3.33 Cr | 2.68 Cr | 1.43 Cr | 2.60 Cr | — |
| Current Liabilities | 9.15 Cr | 12.18 Cr | 16.95 Cr | 9.47 Cr | — |
| Other Current Liabilities | 1.16 Cr | 0.75 Cr | 0.68 Cr | 1.04 Cr | — |
| Current Debt And Capital Lease Obligation | 5.32 Cr | 2.49 Cr | 6.56 Cr | 2.91 Cr | — |
| Current Debt | 5.32 Cr | 2.49 Cr | 6.56 Cr | 2.91 Cr | — |
| Current Provisions | 0.06 Cr | 80000.00 | 80000.00 | 80000.00 | — |
| Payables | 2.62 Cr | 8.25 Cr | 9.58 Cr | 6.13 Cr | — |
| Accounts Payable | 2.62 Cr | 8.23 Cr | 9.55 Cr | 5.48 Cr | — |
| Total Assets | 16.45 Cr | 19.50 Cr | 22.48 Cr | 15.56 Cr | — |
| Total Non Current Assets | 4.07 Cr | 3.76 Cr | 2.92 Cr | 3.11 Cr | — |
| Other Non Current Assets | 0.59 Cr | -2000.00 | 0.59 Cr | 0.59 Cr | — |
| Non Current Deferred Taxes Assets | 6000.00 | 21000.00 | 10000.00 | 11000.00 | — |
| Investmentin Financial Assets | 25000.00 | 25000.00 | 25000.00 | 25000.00 | — |
| Available For Sale Securities | 25000.00 | 25000.00 | 25000.00 | 25000.00 | — |
| Goodwill And Other Intangible Assets | 1.64 Cr | 1.64 Cr | 1.64 Cr | 1.64 Cr | — |
| Other Intangible Assets | 1.64 Cr | 0.03 Cr | 0.03 Cr | 0.03 Cr | — |
| Net PPE | 0.70 Cr | 0.71 Cr | 0.68 Cr | 0.68 Cr | — |
| Gross PPE | 0.70 Cr | 0.92 Cr | 0.88 Cr | 0.88 Cr | — |
| Construction In Progress | 0.00 | 0.00 | 0.00 | 0.00 | — |
| Other Properties | 0.70 Cr | 0.05 Cr | 0.02 Cr | 0.02 Cr | — |
| Current Assets | 12.38 Cr | 15.74 Cr | 19.55 Cr | 12.45 Cr | — |
| Other Current Assets | 0.30 Cr | 0.04 Cr | 0.07 Cr | 0.11 Cr | — |
| Inventory | 2.26 Cr | 2.01 Cr | 2.47 Cr | 2.43 Cr | — |
| Other Receivables | 1.64 Cr | 1.44 Cr | 3.72 Cr | 1.58 Cr | — |
| Accounts Receivable | 8.06 Cr | 11.54 Cr | 12.48 Cr | 7.84 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.12 Cr | 0.17 Cr | 0.14 Cr | 0.05 Cr | — |
| Cash And Cash Equivalents | 0.12 Cr | 0.17 Cr | 0.14 Cr | 0.05 Cr | — |
| Treasury Shares Number | — | 0.00 | — | — | — |
| Retained Earnings | — | 0.64 Cr | 0.09 Cr | -0.51 Cr | -0.84 Cr |
| Other Non Current Liabilities | — | -1000.00 | — | — | -1000.00 |
| Current Deferred Taxes Liabilities | — | 0.27 Cr | 0.14 Cr | 0.02 Cr | — |
| Other Payable | — | 0.01 Cr | 0.03 Cr | 0.65 Cr | 0.57 Cr |
| Total Tax Payable | — | 7000.00 | 7000.00 | 7000.00 | — |
| Non Current Prepaid Assets | — | 0.00 | 0.00 | 0.00 | 189.00 |
| Goodwill | — | 1.61 Cr | 1.61 Cr | 1.61 Cr | 1.61 Cr |
| Accumulated Depreciation | — | -0.22 Cr | -0.21 Cr | -0.20 Cr | -0.20 Cr |
| Machinery Furniture Equipment | — | 0.48 Cr | 0.48 Cr | 0.48 Cr | 0.48 Cr |
| Buildings And Improvements | — | 0.25 Cr | 0.25 Cr | 0.25 Cr | 0.25 Cr |
| Land And Improvements | — | 0.14 Cr | 0.14 Cr | 0.14 Cr | 0.14 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.00 | 0.00 | 2000.00 | 1700.00 |
| Prepaid Assets | — | 0.37 Cr | 0.26 Cr | 0.24 Cr | 0.15 Cr |
| Finished Goods | — | 2.01 Cr | 2.47 Cr | 2.43 Cr | 0.65 Cr |
| Taxes Receivable | — | 0.18 Cr | 0.41 Cr | 0.19 Cr | 0.20 Cr |
| Cash Financial | — | 0.17 Cr | 0.14 Cr | 0.05 Cr | -3.09 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Vivanza Biosciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.